Skip to main content
. 2024 Mar 19;14(3):e075547. doi: 10.1136/bmjopen-2023-075547

Table 1.

Participant characteristics

Participant ID Gender Ethnicity* Age range (years) Role Years of experience of early-phase trials† Clinical area of experience
Participant 1 Male Not collected 25-34 Professional (operational lead at a CTU) 6–10 Cancer
Participant 2 Female Not collected 45–54 Professional (doctor) >16 Cancer
Participant 3 Female Black African 55–64 Patient and public representative Not collected Cancer
Participant 4 Female Not collected 45–54 Professional (statistician) 11–15 Cancer
Participant 5 Male Not collected 35–44 Professional (statistician) 6–10 Cancer
Participant 6 Female British Chinese 65–74 Patient and public representative Not collected Cancer
Participant 7 Female White Canadian 35–44 Patient and public representative Not collected Neurological
Participant 8 Female Not collected 35–44 Professional (nurse) 11–15 Cancer

*Ethnicity only collected for the patient and public representatives.

†Only collected for professional participants.

CTU, clinical trials unit.